


Vive Weight Loss Center operates in Coral Gables, Florida, delivering peptide-based weight management programs and hormone optimization protocols designed for adults seeking medically supervised metabolic interventions. The clinic maintains Better Business Bureau accreditation and focuses exclusively on weight reduction, metabolic health restoration, and age-related hormone decline through pharmaceutical-grade peptide therapies. Patients access both in-person consultations at the Coral Gables facility and telehealth appointments for ongoing program management, allowing flexibility for South Florida residents and those requiring remote monitoring.
Vive Weight Loss Center offers an extensive peptide therapy program with 6 different peptides available, including metabolic peptides including Liraglutide, Semaglutide, growth hormone secretagogues like Ipamorelin, and other specialized compounds. Treatment selection is individualized based on comprehensive health assessments and patient goals.
Vive Weight Loss Center's providers conduct comprehensive intake evaluations including metabolic rate testing, body composition analysis, and hormone level assessment before initiating peptide therapy. The clinical team designs individualized protocols based on patient metabolic profiles, weight loss goals, and contraindication screening. Patients receive instruction on subcutaneous injection technique for self-administered peptides, along with detailed guidance on nutrition timing, macronutrient distribution, and lifestyle modifications that enhance peptide efficacy. The clinic monitors patients through scheduled follow-up appointments that include weight tracking, side effect assessment, and dosage adjustments based on response patterns and tolerance levels.
Patients beginning treatment at the Coral Gables location undergo baseline laboratory work to establish thyroid function, fasting glucose, hemoglobin A1C, lipid panels, and hormone levels before peptide initiation. The clinic provides ongoing access to medical staff for questions about injection site reactions, appetite changes, or gastrointestinal adjustments common during GLP-1 therapy titration. Vive Weight Loss Center structures programs with defined phases: initial weight loss, metabolic stabilization, and maintenance protocols that may transition patients from higher-intensity peptides to lower-dose maintenance regimens. The practice emphasizes sustainable metabolic changes rather than rapid weight reduction, with typical programs spanning several months to allow physiological adaptation.
Vive Weight Loss Center's telehealth platform enables patients across Florida to access peptide therapy consultations, prescription management, and progress monitoring without requiring repeated travel to Coral Gables. The clinic coordinates peptide shipment directly to patients' homes through licensed compounding pharmacies, with video consultations scheduled for dosage reviews and program adjustments. This hybrid model accommodates working professionals, patients with mobility limitations, and those residing in areas without specialized peptide clinics. The practice's 5.0-star rating across 164 Google reviews reflects consistent patient feedback regarding program structure, medical staff responsiveness, and measurable outcomes in weight reduction and metabolic marker improvement, positioning Vive Weight Loss Center as a focused peptide therapy provider in the South Florida medical wellness landscape.
Rafael Olartecoechea
Wegovy injection
Weight loss injection using Semaglutide.
Mounjaro Injection
Weight loss injection using Tirzepatide.
Ozempic injection
Weight loss injection using Semaglutide.
Peptide Therapy for Weight Loss
Therapy using various peptides for weight loss.
NAD+ IV Therapy
IV therapy using NAD+ for health and wellness.
Sermorelin Injections
Hormone therapy using Sermorelin.
Ipamorelin Therapy
Therapy using Ipamorelin for hormone optimization.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.

